88 related articles for article (PubMed ID: 20624388)
41. Effect of hypoxic stress on migration and characteristics of monocytes in uveal melanoma.
Bronkhorst IH; Jehs TM; Dijkgraaf EM; Luyten GP; van der Velden PA; van der Burg SH; Jager MJ
JAMA Ophthalmol; 2014 May; 132(5):614-21. PubMed ID: 24626595
[TBL] [Abstract][Full Text] [Related]
42. Macrophages in uveal melanoma and in experimental ocular tumor models: Friends or foes?
Jager MJ; Ly LV; El Filali M; Madigan MC
Prog Retin Eye Res; 2011 Mar; 30(2):129-46. PubMed ID: 21129496
[TBL] [Abstract][Full Text] [Related]
43. Presence and phenotype of dendritic cells in uveal melanoma.
Polak ME; Borthwick NJ; Johnson P; Hungerford JL; Higgins B; Di Palma S; Jager MJ; Cree IA
Br J Ophthalmol; 2007 Jul; 91(7):971-6. PubMed ID: 17347328
[TBL] [Abstract][Full Text] [Related]
44. Effects of interleukin-1 receptor antagonist on tumor stroma in experimental uveal melanoma.
Triozzi PL; Aldrich W; Singh A
Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5529-35. PubMed ID: 21519029
[TBL] [Abstract][Full Text] [Related]
45. Activated CD11b+ CD15+ granulocytes increase in the blood of patients with uveal melanoma.
McKenna KC; Beatty KM; Bilonick RA; Schoenfield L; Lathrop KL; Singh AD
Invest Ophthalmol Vis Sci; 2009 Sep; 50(9):4295-303. PubMed ID: 19369244
[TBL] [Abstract][Full Text] [Related]
46. High lipid content of irradiated human melanoma cells does not affect cytokine-matured dendritic cell function.
Pizzurro GA; Madorsky Rowdo FP; Pujol-Lereis LM; Quesada-Allué LA; Copati AM; Roberti MP; Teillaud JL; Levy EM; Barrio MM; Mordoh J
Cancer Immunol Immunother; 2013 Jan; 62(1):3-15. PubMed ID: 22722447
[TBL] [Abstract][Full Text] [Related]
47. Lymphocyte subpopulations before therapy in patients with uveal malignant melanoma.
Flynn K; Felberg NT; Koegel A; Hager R; Shields JA; Augsburger JJ; Donoso LA
Am J Ophthalmol; 1986 Feb; 101(2):160-3. PubMed ID: 3946530
[TBL] [Abstract][Full Text] [Related]
48. Serum adsorption, cellular internalization and consequent impact of cuprous oxide nanoparticles on uveal melanoma cells: implications for cancer therapy.
Song H; Xu Q; Zhu Y; Zhu S; Tang H; Wang Y; Ren H; Zhao P; Qi Z; Zhao S
Nanomedicine (Lond); 2015; 10(24):3547-62. PubMed ID: 26467678
[TBL] [Abstract][Full Text] [Related]
49. Effects of melatonin, its precursors and derivatives on the growth of cultured human uveal melanoma cells.
Hu DN; McCormick SA; Roberts JE
Melanoma Res; 1998 Jun; 8(3):205-10. PubMed ID: 9664141
[TBL] [Abstract][Full Text] [Related]
50. Vasculogenic mimicry in tumors. Fact or artifact?
Fausto N
Am J Pathol; 2000 Feb; 156(2):359. PubMed ID: 10666363
[No Abstract] [Full Text] [Related]
51. Characterization of CD4+ T cells primed and boosted by MHCII primary uveal melanoma cell-based vaccines.
Kittler JM; Sommer J; Fischer A; Britting S; Karg MM; Bock B; Atreya I; Heindl LM; Mackensen A; Bosch JJ
Oncotarget; 2019 Mar; 10(19):1812-1828. PubMed ID: 30956760
[TBL] [Abstract][Full Text] [Related]
52. The impact of hyperoxia on the neonatal and adult developing dendritic cell.
Masalunga C; Rozycki HJ; Mainali ES
Pediatr Res; 2007 Jul; 62(1):78-82. PubMed ID: 17515844
[TBL] [Abstract][Full Text] [Related]
53. Choroidal dendritic cells require activation to present antigen and resident choroidal macrophages potentiate this response.
Forrester JV; Lumsden L; Duncan L; Dick AD
Br J Ophthalmol; 2005 Mar; 89(3):369-77. PubMed ID: 15722321
[TBL] [Abstract][Full Text] [Related]
54. Photoimmunotherapy of human uveal melanoma cells.
Hu LK; Hasan T; Gragoudas ES; Young LH
Exp Eye Res; 1995 Oct; 61(4):385-91. PubMed ID: 8549679
[TBL] [Abstract][Full Text] [Related]
55. Successful establishment of uveal and conjunctival melanoma in vitro.
McNamara M; Kennedy SM
In Vitro Cell Dev Biol Anim; 1997 Apr; 33(4):236-9. PubMed ID: 9156336
[No Abstract] [Full Text] [Related]
56. Lymphocyte subpopulations in uveal malignant melanoma.
Kaplan HJ
Am J Ophthalmol; 1986 Apr; 101(4):483-5. PubMed ID: 3963109
[No Abstract] [Full Text] [Related]
57. [Key role of apoptosis in progressing uveal melanoma].
Ziangirova GG; Likhvantseva VG; Ukhov IuI; Sutulov AIu
Izv Akad Nauk Ser Biol; 2003; (5):527-33. PubMed ID: 14735781
[TBL] [Abstract][Full Text] [Related]
58. Dendritic cells in melanoma - immunohistochemical study and research trends.
Nedelcu RI; Ion DA; Holeab CA; Cioplea MD; Brînzea A; Zurac SA
Rom J Morphol Embryol; 2015; 56(3):997-1002. PubMed ID: 26662131
[TBL] [Abstract][Full Text] [Related]
59. Butein and its emerging anti-proliferative and pro-apoptotic effects in systemic malignancies.
Kapoor S
Curr Eye Res; 2013 Jul; 38(7):810. PubMed ID: 23621171
[No Abstract] [Full Text] [Related]
60. The extent to which melanoma alters tissue-resident dendritic cell function correlates with tumorigenicity.
Hargadon KM
Oncoimmunology; 2016; 5(1):e1069462. PubMed ID: 26942090
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
